Literature DB >> 16807310

Use of antipsychotics among nonagenarian residents in long-term institutional care in Finland.

Hanna-Mari Alanen1, Harriet Finne-Soveri, Anja Noro, Esa Leinonen.   

Abstract

BACKGROUND: There is a paucity of information about the use of antipsychotic medication in long-term care, especially among the oldest-old residents.
OBJECTIVE: To analyse the factors associated with the use of antipsychotic medication among nonagenarian residents in long-term institutional care.
DESIGN: A retrospective study was designed from cross-sectional data, gathered in the period 1 January 2003 to 30 June 2003, in Finland. Data were extracted from the Resident Assessment Instrument database, based on Minimum Data Set 2.0 assessments.
SETTING: Data were provided by 23 hospital-based institutions and 43 residential homes.
SUBJECTS: Residents aged >or=90 years were included, consisting of 1,334 resident assessments.
RESULTS: Almost a third of the residents received one or more antipsychotic medication. In the logistic regression analysis, factors associated with the use of antipsychotics among nonagenarian residents were as follows: socially inappropriate or disruptive behavioural symptoms [odds ratio (OR) 1.86, 95% confidence interval (CI) 1.36-2.54], concomitant anxiolytic medication (OR 1.83, 95% CI 1.39-2.42), recurring anxious complaints (OR 1.61, 95% CI 1.17-2.22), recurring physical movements (OR 1.43, 95% CI 1.08-1.91) and unsettled relationships (OR 1.35, 95% CI 1.15-1.57). A good sense of initiative or involvement was significantly less likely to be associated with antipsychotics (OR 0.86, 95% CI 0.80-0.94). There were no associations between any psychiatric diagnoses or symptoms and the use of antipsychotics.
CONCLUSIONS: Antipsychotic medication use in nonagenarians in long-term institutions was common and seemed in many cases to be associated with residents' negative attitudes to others. Querulous residents received antipsychotics more commonly than those with good social skills. Clearly defined indications may not be fulfilled in many cases, and an evaluation of treatment may be lacking. These may indicate that in Finland, there could be a considerable gap between antipsychotic medication recommendations and actual clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807310     DOI: 10.1093/ageing/afl065

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  12 in total

1.  Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study.

Authors:  Helka M V Hosia-Randell; Seija M Muurinen; Kaisu H Pitkälä
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 2.  Antipsychotic Use in Dementia.

Authors:  Julia Kirkham; Chelsea Sherman; Clive Velkers; Colleen Maxwell; Sudeep Gill; Paula Rochon; Dallas Seitz
Journal:  Can J Psychiatry       Date:  2016-10-08       Impact factor: 4.356

Review 3.  Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.

Authors:  Marta Miarons; Christopher Cabib; Francisco Javier Barón; Laia Rofes
Journal:  Eur J Clin Pharmacol       Date:  2017-08-05       Impact factor: 2.953

4.  Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study.

Authors:  Zhanlian Feng; John P Hirdes; Trevor F Smith; Harriet Finne-Soveri; Iris Chi; Jean-Noel Du Pasquier; Ruedi Gilgen; Naoki Ikegami; Vincent Mor
Journal:  Int J Geriatr Psychiatry       Date:  2009-10       Impact factor: 3.485

5.  Psychotropic medication use among elderly nursing home residents in Slovenia: cross-sectional study.

Authors:  Marija Petek Šter; Eva Cedilnik Gorup
Journal:  Croat Med J       Date:  2011-02       Impact factor: 1.351

6.  Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities.

Authors:  Kang Soo Lee; Sang-Hwan Kim; Hee-Jin Hwang
Journal:  Drugs Real World Outcomes       Date:  2015-11-25

7.  Detailed analysis of the impact of age on the QT interval.

Authors:  Simon W Rabkin; Xin-Bo Justin Cheng; Darby Js Thompson
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

8.  Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.

Authors:  Kathryn J Stock; Joseph E Amuah; Kate L Lapane; David B Hogan; Colleen J Maxwell
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

9.  Psychotropic medication use among nursing home residents in Austria: a cross-sectional study.

Authors:  Eva Mann; Sascha Köpke; Burkhard Haastert; Kaisu Pitkälä; Gabriele Meyer
Journal:  BMC Geriatr       Date:  2009-05-21       Impact factor: 3.921

10.  Antipsychotics in Alzheimer's disease: A critical analysis.

Authors:  Eduardo Marques da Silva; Rafaela de Castro Oliveira Pereira Braga; Thiago Junqueira Avelino-Silva; Luiz Antonio Gil Junior
Journal:  Dement Neuropsychol       Date:  2011 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.